Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
New Topical Formulations in Atopic Dermatitis
NCT02732314Phase 4Completed
- Sponsor
- Procter & Gamble
- Start
- Mar 2016
- Primary completion
- Jun 2016
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Investigational OTC Cream in atopic dermatitis (AD) (4 arms), sponsored by Procter & Gamble. Primary endpoint: Severity Scoring of Atopic Dermatitis at 12 weeks. Started Mar 2016; status: completed.
02
Drugs
Investigational OTC Cream
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT02732314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02732314.